Gapping down
In reaction to disappointing earnings/guidance:
- CONN -28.3%, ROAD -15%, DBI -15%, CASY -5.9%, CHWY -2.4%, TSM -0.6% (Nov revs)
Other news:
- CNST -5.9% (commenced public offering of 4.75 mln shares of common stock)
- LVGO -5.6% (announced public offering of 2.78 mln shares of common stock by selling stockholders)
- ABR -3.5% (upsizes offering by 500K shares and prices 6.5 mln shares of common stock at for gross proceeds of $91.9 mln)
- REGN -3.3% (reports indicate that Sanofi [SNY] could sell its stake in the company following lock-up expiration)
- AMRX -1.7% (to acquire 65.1% majority interest in AvKARE and its related affiliate for an implied enterprise value of $340 mln)
- BLUE -1.1% (reported updated data for bb21217 and for LentiGlobin gene therapy)
Analyst comments:
- NFLX -2.4% (downgraded to Underperform at Needham)
- CHD -2% (downgraded to Underweight at JP Morgan)
- VTR -0.8% (downgraded to Underperform at Wells Fargo)